Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

07/11/2025 06:35

Nov 7 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             10.24               10.00            20.69    
                 (+2.4 pct)          (+1.4 pct)       (+2.8 pct)  
  Operating        379 mln             337 mln          775 mln   
                 (+12.4 pct)         (+16.0 pct)      (+9.9 pct)  
  Recurring        389 mln             343 mln          771 mln   
                 (+13.6 pct)         (+15.8 pct)      (+8.9 pct)  
  Net              250 mln             222 mln          505 mln   
                 (+12.8 pct)         (-1.7 pct)       (+9.0 pct)  
  EPS             80.40 yen           70.87 yen       162.13 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T